Masimo to Report Second Quarter 2016 Financial Results after Market Close on Wednesday, August 3
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET)
Masimo (NASDAQ: MASI) announced today that it will release financial results for the second quarter ended July 2, 2016, after
the market closes on Wednesday, August 3, 2016. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET)
and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief
Financial Officer.
A live webcast of the conference call will be available online from the investor relations page of the company's corporate
website at www.masimo.com. The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706) 758-3929 for
international callers. The reservation code for both dial-in numbers is 52627919. After the live webcast, the call will be
available on Masimo's website through August 17, 2016. In addition, a telephonic replay of the call will be available through
August 31, 2016. The replay dial-in numbers are (855) 859-2056 for domestic callers and +1 (404) 537-3406 for international
callers. Please use reservation code 52627919.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient
outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. In 1995, the company debuted
Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to significantly
reduce false alarms and accurately monitor for true alarms. Masimo SET® is estimated to be used on more than 100 million patients
in leading hospitals and other healthcare settings around the world. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry
technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively,
including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and more recently,
Pleth Variability Index (PVI®) and Oxygen Reserve Index (ORI™), in addition to SpO2, pulse rate, and perfusion index (PI). In 2014,
Masimo introduced Root®, an intuitive patient monitoring and connectivity platform with the Masimo Open Connect (MOC-9™) interface.
Masimo is also taking an active leadership role in mHealth with products such as the Radius-7™ wearable patient monitor and the
MightySat™ fingertip pulse oximeter. Additional information about Masimo and its products may be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care by Taking Noninvasive
Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks or registered trademarks of
Masimo.
Masimo
Investor Contact:
Eli Kammerman, (949) 297-7077
ekammerman@masimo.com
or
Media Contact:
Irene Paigah, (858) 859-7001
irenep@masimo.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160720005443/en/